Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 12:44:32 UTC |
---|
Update Date | 2021-09-26 23:07:21 UTC |
---|
HMDB ID | HMDB0253848 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide |
---|
Description | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. Based on a literature review very few articles have been published on (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-2-amino-n-[(1s)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C InChI=1S/C26H42N4O5S2/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31) |
---|
Synonyms | Value | Source |
---|
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulphonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulphonylbutanamide | Generator |
|
---|
Chemical Formula | C26H42N4O5S2 |
---|
Average Molecular Weight | 554.77 |
---|
Monoisotopic Molecular Weight | 554.259662816 |
---|
IUPAC Name | 2-amino-N-[7,7-dimethyl-1-({[4-(2-methylphenyl)piperazin-1-yl]sulfonyl}methyl)bicyclo[2.2.1]heptan-2-yl]-4-methanesulfonylbutanamide |
---|
Traditional Name | 2-amino-N-(7,7-dimethyl-1-{[4-(2-methylphenyl)piperazin-1-ylsulfonyl]methyl}bicyclo[2.2.1]heptan-2-yl)-4-methanesulfonylbutanamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC=CC=C1N1CCN(CC1)S(=O)(=O)CC12CCC(CC1NC(=O)C(N)CCS(C)(=O)=O)C2(C)C |
---|
InChI Identifier | InChI=1S/C26H42N4O5S2/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31) |
---|
InChI Key | MWIASLNTAGRGGA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | Phenylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- Phenylpiperazine
- N-arylpiperazine
- Alpha-amino acid or derivatives
- Aromatic monoterpenoid
- Norbornane monoterpenoid
- Bornane monoterpenoid
- Monoterpenoid
- Bicyclic monoterpenoid
- Aminotoluene
- Aniline or substituted anilines
- Dialkylarylamine
- Tertiary aliphatic/aromatic amine
- Toluene
- Benzenoid
- Organosulfonic acid amide
- Organic sulfonic acid amide
- Fatty amide
- Fatty acyl
- Monocyclic benzene moiety
- N-acyl-amine
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Sulfone
- Amino acid or derivatives
- Tertiary amine
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Primary aliphatic amine
- Organic nitrogen compound
- Amine
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Organosulfur compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Predicted by Siyang on May 30, 2022 | 15.0245 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.57 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2596.2 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 170.1 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 231.9 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.8 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 157.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 581.7 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 546.2 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 149.2 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1264.8 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 550.5 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1739.7 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 385.3 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 423.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 206.2 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 144.4 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC1 | 4559.7 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC1 | 4519.2 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)C3(C)C)CC1 | 5573.2 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC1 | 4412.9 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC1 | 4513.1 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C)C3(C)C)CC1 | 6085.8 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4387.6 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4659.9 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 5344.5 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4589.2 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4753.6 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 5427.1 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4443.7 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 4882.4 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C3(C)C)CC1 | 5166.2 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4789.8 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4804.8 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5593.8 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4673.5 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4791.2 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,1TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(N)CCS(C)(=O)=O)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 6087.0 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4875.8 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5195.7 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5396.8 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 4992.4 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5247.6 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,2TBDMS,isomer #2 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5437.0 | Standard polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5083.0 | Semi standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5610.4 | Standard non polar | 33892256 | (2S)-2-Amino-N-[(1S)-7,7-dimethyl-1-[[4-(2-methylphenyl)piperazin-1-yl]sulfonylmethyl]-2-bicyclo[2.2.1]heptanyl]-4-methylsulfonylbutanamide,3TBDMS,isomer #1 | CC1=CC=CC=C1N1CCN(S(=O)(=O)CC23CCC(CC2N(C(=O)C(CCS(C)(=O)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C3(C)C)CC1 | 5206.4 | Standard polar | 33892256 |
|
---|